The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox
Abstract
Fragile X syndrome results from mutations in a (CGG)n repeat found in the coding sequence of the FMR-1 gene. Analysis of length variation in this region in normal individuals shows a range of allele sizes varying from a low of 6 to a high of 54 repeats. Premutations showing no phenotypic effect in fragile X families range in size from 52 to over 200 repeats. All alleles with greater than 52 repeats, including those identified in a normal family, are meiotically unstable with a mutation frequency of one, while 75 meioses of alleles of 46 repeats and below have shown no mutation. Premutation alleles are also mitotically unstable as mosaicism is observed. The risk of expansion during oogenesis to the full mutation associated with mental retardation increases with the number of repeats, and this variation in risk accounts for the Sherman paradox.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXS is caused by mutations in the FMR1 gene, which is located on the X chromosome and whose locus at Xq27.3 coincides with the folate-sensitive fragile site (4, 5).”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [5]
Citations
Cites
Hypervariable ‘minisatellite’ regions in human DNA
Jeffreys, A. J., Wilson, V., & Thein, S. L. (1985) · Nature · doi:10.1038/314067a0 · Cited by 3,771
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Absence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Self-citationDNA typing and genetic mapping with trimeric and tetrameric tandem repeats.
Edwards, A., Civitello, A. B., Hammond, H. A., & Caskey, C. T. (1991) · Europe PMC (PubMed Central) · Cited by 1,147
Self-citationMapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n
Kremer, E., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S., Schlessinger, D., Sutherland, G., & Richards, R. (1991) · Science · doi:10.1126/science.1675488 · Cited by 929
Self-citationFragile X Genotype Characterized by an Unstable Region of DNA
Yu, S., Pritchard, M. A., Kremer, E. J., Lynch, M., Nancarrow, J. K., Baker, E. G., Holman, K., Mulley, J. C., Warren, S. T., Schlessinger, D., et al. (1991) · Science · doi:10.1126/science.252.5009.1179 · Cited by 793
Self-citationJeffreys, A. J., Royle, N. J., Wilson, V., & Wong, Z. Y. H. (1988) · Nature · doi:10.1038/332278a0 · Cited by 759
Stark, G. R., & Wahl, G. M. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.002311 · Cited by 583
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J. B., Cann, H. M., Cohen, D., Lathrop, M. G., Lalouel, J.-M., & White, R. L. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Cited by
Sorted by citations
Items 301–400 of 1,005
Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
Siegelmann‐Danieli, N., & Buetow, K. H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690071 · Cited by 113
Screening for fragile X syndrome: a literature review and modelling study
Song, F., Barton, P., Sleightholme, V., Yao, G., & Fry-Smith, A. (2003) · Health Technology Assessment · doi:10.3310/hta7160 · Cited by 114
Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies
Ryynänen, M., Heinonen, S. T., Makkonen, M., Kajanoja, E., Mannermaa, A., & Pertti, K. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200285 · Cited by 112
Molecular‐neurobehavioral associations in females with the fragile X full mutation
Abrams, M. T., Reiss, A. L., Freund, L. S., Baumgardner, T. L., Chase, G. A., & DENCKLA, M. B. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510407 · Cited by 112
AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission
Yrigollen, C. M., Martorell, L., Durbin-Johnson, B. P., Naudó, M., Genovès, J., Murgia, A., Polli, R., Zhou, L., Barbouth, D., Deppen, A. R., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-24 · Cited by 110
Debrauwère, H., Gendrel, C., Lechat, S., & Dutreix, M. (1997) · Biochimie · doi:10.1016/s0300-9084(97)82006-8 · Cited by 111
Tremor and ataxia in fragile X premutation carriers: Blinded videotape study
Berry‐Kravis, E., Lewin, F., Wuu, J., Leehey, M., Hagerman, R., Hagerman, P., & Goetz, C. G. (2003) · Annals of Neurology · doi:10.1002/ana.10522 · Cited by 109
Godler, D. E., Tassone, F., Loesch, D. Z., Taylor, A. K., Gehling, F., Hagerman, R. J., Burgess, T., Ganesamoorthy, D., Hennerich, D., Gordon, L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq037 · Cited by 106
Brunner, H. G., Brüggenwirth, H. T., Nillesen, W., Jansen, G., Hamel, B. C. J., Hoppe, R. L. E., de Die-Smulders, C. E. M., Höweler, C., van Oost, B. A., & Wieringa, B. (1993) · PubMed · Cited by 108
Genetic disorders in premature ovarian failure
Laml, T. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.5.483 · Cited by 108
Naumann, A., Hochstein, N., Weber, S., Fanning, E., & Doerfler, W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.018 · Cited by 107
Population studies of the fragile X: a molecular approach.
Jacobs, P. A., Bullman, H., Macpherson, J., Youings, S. A., Rooney, V., Watson, A., & Dennis, N. R. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.6.454 · Cited by 107
Howarth, J. L., Kelly, S., Keasey, M. P., Glover, C. P. J., Lee, Y.-B., Mitrophanous, K. A., Chapple, J. P., Gallo, J., Cheetham, M. E., & Uney, J. B. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300163 · Cited by 109
Kamm, C., Healy, D. G., Quinn, N. P., Wüllner, U., Möller, J. C., Schöls, L. J., Geser, F., Bürk, K., Børglum, A. D., Pellecchia, M. T., et al. (2005) · Brain · doi:10.1093/brain/awh535 · Cited by 106
Slegtenhorst-Eegdeman, K. E., de Rooij, D. G., Verhoef‐Post, M., van de Kant, H. J. G., Bakker, C. E., Oostra, B. A., Grootegoed, J. A., & Themmen, A. P. N. (1998) · Endocrinology · doi:10.1210/endo.139.1.5706 · Cited by 107
Self-citationDNA repeat expansions and human disease
Usdin, K., & Grabczyk, E. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000734 · Cited by 106
Nadel, Y., Weisman-Shomer, P., & Fry, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28970 · Cited by 106
Hantash, F. M., Goos, D. M., Crossley, B., Anderson, B., Zhang, K., Sun, W., & Strom, C. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181fa9fad · Cited by 105
Familial Parkinson’s Disease: A Clinical Genetic Analysis
Bonifati, V., Fabrizio, E., Vanacore, N., de Mari, M., & Meco, G. (1995) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100039469 · Cited by 119
cDNAs with long CAG trinucleotide repeats from human brain
Margolis, R. L., Abraham, M. R., Gatchell, S. B., Li, S.-H., Kidwai, A. S., Breschel, T. S., Stine, O., Callahan, C., McInnis, M., & Ross, C. A. (1997) · Human Genetics · doi:10.1007/s004390050476 · Cited by 112
Fragile X syndrome: From protein function to therapy
Bagni, C., & Oostra, B. A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36241 · Cited by 110
Self-citationGenetic Basis of Intellectual Disability
Ellison, J. W., Rosenfeld, J. A., & Shaffer, L. G. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-140053 · Cited by 110
The CAG–polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology
Stoyas, C. A., & Spada, A. R. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00011-7 · Cited by 106
Leman, A. R., & Noguchi, E. (2013) · Genes · doi:10.3390/genes4010001 · Cited by 102
Stetler, A., Winograd, C., Sayegh, J., Cheever, A., Patton, E., Zhang, X., Clarke, S. G., & Ceman, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi429 · Cited by 103
Eichler, E. E. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.3.319 · Cited by 103
The DNA Replication Program Is Altered at the FMR1 Locus in Fragile X Embryonic Stem Cells
Gerhardt, J., Tomishima, M. J., Zaninović, N., Colak, D., Yan, Z., Zhan, Q., Rosenwaks, Z., Jaffrey, S. R., & Schildkraut, C. L. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.029 · Cited by 104
Richard, G., Dujon, B., & Haber, J. E. (1999) · Molecular and General Genetics MGG · doi:10.1007/s004380050031 · Cited by 106
Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome
Jawaid, S., Kidd, G. J., Wang, J., Swetlik, C., Dutta, R., & Trapp, B. D. (2017) · Glia · doi:10.1002/glia.23284 · Cited by 93
Saluto, A., Brussino, A., Tassone, F., Arduino, C., Cagnoli, C., Pappi, P., Hagerman, P. J., Migone, N., & Brusco, A. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60594-6 · Cited by 100
Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism
Loesch, D. Z., Khaniani, M. S., Slater, H., Rubio, J. P., Bui, M., Kotschet, K. E., D'Souza, W. J., Venn, A., Kalitsis, P., Choo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01275.x · Cited by 100
Wöhrle, D., Salat, U., Gläser, D., Mücke, J., Meisel-Stosiek, M., Schindler, D., Vogel, W., & Steinbach, P. J. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.2.103 · Cited by 99
Brouwer, J. R., Huizer, K., Severijnen, L.-A. W. F. M., Hukema, R. K., Berman, R. F., Oostra, B. A., & Willemsen, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05747.x · Cited by 99
Self-citationTrinucleotide repeat length and rate of progression of Huntington's disease
Illarioshkin, S. N., Igarashi, S., Onodera, O., Markova, E. D., Nikolskaya, N. N., Tanaka, H., Tz, C., Insarova, N. G., Endo, K., Ivanova‐Smolenskaya, I. A., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410360412 · Cited by 99
Fragile X Mental Retardation Protein FMRP Binds mRNAs in the Nucleus
Kim, M., Bellini, M., & Ceman, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01377-08 · Cited by 98
The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons
Poletti, A. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.03.001 · Cited by 100
Hoekert, W. E. J., Neuféglise, H., Schouten, A. D., & Menken, S. B. J. (2002) · Heredity · doi:10.1038/sj.hdy.6800103 · Cited by 97
Fragile X Syndrome: The FMR1 CGG Repeat Distribution Among World Populations
Peprah, E. K. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00694.x · Cited by 96
Fragile X syndrome due to a missense mutation
Myrick, L. K., Nakamoto-Kinoshita, M., Lindor, N. M., Kirmani, S., Cheng, X., & Warren, S. T. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.311 · Cited by 109
Self-citationEvolution of genetic redundancy for advanced players
Dover, G. A. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90012-e · Cited by 95
Neuropathic features in fragile X premutation carriers
Berry‐Kravis, E., Goetz, C. G., Leehey, M. A., Hagerman, R. J., Zhang, L., Li, L., Nguyen, D. V., Hall, D. A., Tartaglia, N. R., Cogswell, J. B., et al. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31559 · Cited by 95
Fragile X syndrome and the (CGG)n mutation: two families with discordant MZ twins.
Kruyer, H., Milà, M., Glover, G., Carbonell, P., Ballesta, F., & Estivill, X. (1994) · PubMed Central · Cited by 95
White, P. J., Borts, R. H., & Hirst, M. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5675 · Cited by 94
Ohshima, K., & Wells, R. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16798 · Cited by 95
A systematic review of population screening for fragile X syndrome
Hill, M. K., Archibald, A. D., Cohen, J., & Metcalfe, S. A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181e38fb6 · Cited by 95
Pramparo, T., Pierce, K., Lombardo, M. V., Barnes, C. C., Marinero, S., Ahrens‐Barbeau, C., Murray, S. S., Lopez, L., Xu, R., & Courchesne, E. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3008 · Cited by 93
Local and global functions of Timeless and Tipin in replication fork protection
Leman, A. R., & Noguchi, E. (2012) · Cell Cycle · doi:10.4161/cc.21989 · Cited by 99
Eadie, B. D., Zhang, W. N., Boehme, F., Gil‐Mohapel, J., Kainer, L., Simpson, J. M., & Christie, B. R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.001 · Cited by 95
Severe neuropathy with leaky connexin32 hemichannels
Liang, G. S. L., de Miguel, M., Gómez‐Hernández, J. M., Glass, J. D., Scherer, S. S., Mintz, M., Barrio, L. C., & Fischbeck, K. H. (2005) · Annals of Neurology · doi:10.1002/ana.20459 · Cited by 94
Fragile X carrier screening and FMR1 allele distribution in the Japanese population
Otsuka, S., Sakamoto, Y., Siomi, H., Itakura, M., Yamamoto, K., Matumoto, H., Sasaki, T., Kato, N., & Nanba, E. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.12.015 · Cited by 95
SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia
Holmes, S. E., Hearn, E. O., Ross, C. A., & Margolis, R. L. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00596-2 · Cited by 94
Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.
Vries, B. B. A. D., Fryns, J. P., Butler, M. G., Canziani, F., Swaay, E. W., Hemel, J. O. V., Oostra, B. A., Halley, D. J. J., & Niermeijer, M. F. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.9.761 · Cited by 94
Self-citationTrinucleotide Repeat Expansion and Neuropsychiatric Disease
Margolis, R. L., McInnis, M. G., Rosenblatt, A., & Ross, C. A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1019 · Cited by 95
Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone
Cao, Z., Hulsizer, S., Tassone, F., Tang, H.-T., Hagerman, R. J., Rogawski, M. A., Hagerman, P. J., & Pessah, I. N. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds118 · Cited by 94
Penetrance and expressivity in the molecular age
Zlotogora, J. (2003) · Genetics in Medicine · doi:10.1097/01.gim.0000086478.87623.69 · Cited by 93
Facile FMR1 mRNA structure regulation by interruptions in CGG repeats
Напиерала, М. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki186 · Cited by 93
Anticipation in Swedish families with bipolar affective disorder.
Nylander, P.-O., Engström, C., Chotai, J., Wahlström, J., & Adolfsson, R. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.9.686 · Cited by 93
Tabolacci, E., Pietrobono, R., Moscato, U., Oostra, B. A., Chiurazzi, P., & Neri, G. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201393 · Cited by 92
Self-citationGuidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation.
Oostra, B. A., Jacky, P. B., Brown, W. T., & Rousseau, F. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.5.410 · Cited by 92
Self-citationA voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome
Hashimoto, R., Javan, A. K., Tassone, F., Hagerman, R. J., & Rivera, S. M. (2011) · Brain · doi:10.1093/brain/awq368 · Cited by 91
Qin, M., Entezam, A., Usdin, K., Huang, T., Liu, Z., Hoffman, G. E., & Smith, C. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.008 · Cited by 91
Chen, L., Hadd, A. G., Sah, S., Houghton, J. F., Filipovic-Sadic, S., Zhang, W., Hagerman, P. J., Tassone, F., & Latham, G. J. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31820a780f · Cited by 91
Biancalana, V., Glaeser, D., McQuaid, S., & Steinbach, P. J. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.185 · Cited by 97
X-linked premature ovarian failure: a complex disease
Toniolo, D. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.04.005 · Cited by 91
Behavioral and Psychiatric Disorders in Adult Male Carriers of Fragile X
DORN, M. B., Mazzocco, M. M. M., & Hagerman, R. J. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199402000-00015 · Cited by 90
Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome
Floros, J., Veletza, S. V., Kotikalapudi, P., Križková, L., Karinch, A. M., Friedman, C. A., Buchter, S., & Marks, K. (1995) · Biochemical Journal · doi:10.1042/bj3050583 · Cited by 90
Update on the implication of potassium channels in autism: K+ channelautism spectrum disorder
Guglielmi, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00034 · Cited by 89
RNA transport and localized protein synthesis in neurological disorders and neural repair
Wang, W., van Niekerk, E. A., Willis, D. E., & Twiss, J. L. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20511 · Cited by 91
Insights from Mouse Models into the Molecular Basis of Neurodegeneration
Heintz, N., & Zoghbi, H. Y. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.779 · Cited by 89
Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations.
Davies, J. L., Yamagata, H. D., Shelbourne, P., Buxton, J. L., Ogihara, T., Nokelainen, P. T., Nakagawa, M., Williamson, R., Johnson, K. J., & Miki, T. (1992) · Journal of Medical Genetics · doi:10.1136/jmg.29.11.766 · Cited by 89
Yeast ARMs (DNA at-risk motifs) can reveal sources of genome instability
Gordenin, D. A., & Resnick, M. A. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00047-5 · Cited by 89
Progress in the Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology
McCarroll, S. A., & Hyman, S. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.046 · Cited by 90
Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve
Gleicher, N., Weghofer, A., Oktay, K., & Barad, D. H. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60173-3 · Cited by 88
Moon, J., Beaudin, A. E., Verosky, S. C., Driscoll, L. L., Weiskopf, M., Levitsky, D. A., Crnic, L. S., & Strupp, B. J. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.6.1367 · Cited by 91
Role of proteolysis in polyglutamine disorders
Tarlac, V., & Storey, E. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10746 · Cited by 88
Gain of glutamines, gain of function?
Housman, D. (1995) · Nature Genetics · doi:10.1038/ng0595-3 · Cited by 94
Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice
Lu, C., Lin, L., Tan, H., Wu, H., Sherman, S. L., Gao, F., Jin, P., & Chen, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds348 · Cited by 87
Understanding fragile X syndrome: insights from animal models
Bakker, C. E., & Oostra, B. A. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072845 · Cited by 90
Self-citationPAK in Alzheimer disease, Huntington disease and X-linked mental retardation
Ma, Q., Yang, F., Frautschy, S. A., & Cole, G. M. (2012) · Cellular Logistics · doi:10.4161/cl.21602 · Cited by 87
Yang, Z., Lau, R., Marcadier, J. L., Chitayat, D. A., & Pearson, C. E. (2003) · The American Journal of Human Genetics · doi:10.1086/379523 · Cited by 86
Molecular and cellular genetics of fragile X syndrome
Kaufmann, W. E., & Reiss, A. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1 · Cited by 88
Santos, A. R., Kanellopoulos, A. K., & Bagni, C. (2014) · Learning & Memory · doi:10.1101/lm.035956.114 · Cited by 91
Hashimoto, R., Backer, K. C., Tassone, F., Hagerman, R. J., & Rivera, S. M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.030 · Cited by 85
Godde, J., Kass, S., Hirst, M., & Wolffe, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24325 · Cited by 90
Vries, B. B. A. D., Jansen, C. C., Duits, A., Verheij, C., Willemsen, R., Hemel, J. O. V., van den Ouweland, A. M., Niermeijer, M. F., Oostra, B. A., & Halley, D. J. J. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.12.1007 · Cited by 85
Self-citationPrice, E. A., Bourne, S., Radbourne, R., Lawton, P. A., Lamerdin, J. E., Thompson, L. H., & Arrand, J. E. (1997) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02674415 · Cited by 85
Fragile X-associated tremor/ataxia syndrome
Leehey, M. A., & Hagerman, P. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00023-1 · Cited by 84
Why is SCA12 different from other SCAs?
Holmes, S. E., O’Hearn, E., & Margolis, R. L. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072854 · Cited by 84
Best practices: antenatal screening for common genetic conditions other than aneuploidy
Ram, K. T., & Klugman, S. D. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3283372379 · Cited by 83
Hantash, F. M., Goos, D. M., Tsao, D., Quan, F., Buller‐Burckle, A., Peng, M., Jarvis, M., Sun, W., & Strom, C. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d0d40e · Cited by 83
Chromosomal fragile site breakage by EBV-encoded EBNA1 at clustered repeats
Li, J. S. Z., Abbasi, A., Kim, D. H., Lippman, S. M., Alexandrov, L. B., & Cleveland, D. W. (2023) · Nature · doi:10.1038/s41586-023-05923-x · Cited by 81
Beilina, A. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh053 · Cited by 84
Khateb, S., Weisman-Shomer, P., Hershco-Shani, I., Ludwig, A. L., & Fry, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm636 · Cited by 87
Trinucleotide Repeat Instability: Genetic Features and Molecular Mechanisms
Spada, A. R. L. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00895.x · Cited by 83
Sermon, K. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00572-x · Cited by 82
Woodcock, K. A., Oliver, C., & Humphreys, G. W. (2008) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2008.01122.x · Cited by 91
Hippocampal dysfunction and cognitive impairment in Fragile-X Syndrome
Bostrom, C. A., Yau, S., Majaess, N. M., Vetrici, M. A., Gil‐Mohapel, J., & Christie, B. R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.033 · Cited by 87
Somatic mosaicism in patients with Angelman syndrome and an imprinting defect
Nazlican, H., Zeschnigk, M., Claussen, U., Michel, S., Böehringer, S., Gillessen‐Kaesbach, G., Buiting, K., & Horsthemke, B. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh296 · Cited by 82
Gall-Duncan, T., Sato, N. J., Yuen, R. K. C., & Pearson, C. E. (2021) · Genome Research · doi:10.1101/gr.269530.120 · Cited by 77
Kumari, D., Swaroop, M., Southall, N. T., Huang, W., Zheng, W., & Usdin, K. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0278 · Cited by 83
Metadata
- Authors
- Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., Oostra, B. A., Nelson, D. L., & Caskey, C. T.
- Affiliations
- Howard Hughes Medical Institute (US)
- Queen's University (CA)
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 67
- Issue
- 6
- Pages
- 1047-1058
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2167119720
- Cited by
- 2,080
- References
- 25
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 36 · 2023: 22 · 2022: 31 · 2021: 41 · 2020: 43 · 2019: 37 · 2018: 49 · 2017: 34 · 2016: 65 · 2015: 56 · 2014: 78 · 2013: 68 · 2012: 70
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Human Genome Research Institute (HG00038)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20521)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- fragile X syndrome, CGG repeat, FMR1 gene, premutation, repeat expansion, meiotic instability, mitotic instability, mosaicism, repeat length variation, oogenesis, intellectual disability
- MeSH terms
- Alleles, Base Sequence, Exons, Fragile X Syndrome, Genes, Humans, Meiosis, Methylation, Molecular Sequence Data, Mosaicism, Oligodeoxyribonucleotides, Pedigree, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Risk Factors, X Chromosome, Restriction Mapping, Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review